WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Adaptive Biotechnologies earnings were -$49.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ADPT earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$20.0M, up 47.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADPT reported annual earnings of -$59.5M, with -62.7% growth.

ADPT earnings history

Current Revenue
$295.4M
Current Earnings
-$49.7M
Current Profit Margin
-16.8%

ADPT Return on Equity

Current Company
-24.3%
Current Industry
-141.9%
Current Market
13.5%
ADPT's Return on Equity (-24.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ADPT Return on Assets

Current Company
-9.9%
Current Industry
-13.7%
ADPT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ADPT announces earnings.

ADPT Return on Capital Employed

Current Company
-9.05%
Current Industry
-9.6%
ADPT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADPT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ADPT-$15.48M-$49.68MN/A-$0.33
RLAY-$269.85M-$272.71MN/A-$1.56
ALMS-$240.44M-$237.42MN/A-$1.96
DNLI-$492.55M-$508.02MN/A-$2.88
RCUS-$343.00M-$369.00MN/A-$3.19
View Top Biotech Stocks

Adaptive Biotechnologies Earnings Reports & History FAQ

What were Adaptive Biotechnologies's earnings last quarter?

On ADPT's earnings call on May 6, 2026, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 2026 earnings per share (EPS) of -$0.13, up 35% year over year. Total ADPT earnings for the quarter were -$20.03 million. In the same quarter last year, Adaptive Biotechnologies's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.

Is Adaptive Biotechnologies profitable or losing money?

As of the last Adaptive Biotechnologies earnings report, Adaptive Biotechnologies is currently losing money. Adaptive Biotechnologies's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$49.68 million, a 64.97% decrease year over year.

What was ADPT's earnings growth in the past year?

As of Adaptive Biotechnologies's earnings date in May 6, 2026, Adaptive Biotechnologies's earnings has grown year over year. ADPT earnings in the past year totalled -$49.68 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.